Zhejiang Xinguang Pharmaceutical Co., Ltd. logo

Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
14. 28
-0.07
-0.4878%
¥
2.58B Market Cap
- P/E Ratio
1.2% Div Yield
4.79M Volume
- Eps
¥ 14.35
Previous Close
Add Transaction
Day Range
14.2 14.5
Year Range
11.53 18.65
Want to track 300519 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300519 closed today lower at ¥14.28, a decrease of -0.4878% from yesterday's close, completing a monthly increase of 20% or ¥2.38. Over the past 12 months, 300519 stock lost -4.2254%.
300519 pays dividends to its shareholders, with the most recent payment made on May 29, 2026. The next estimated payment will be in In 9 months on May 29, 2027 for a total of ¥0.3.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0.1534%. On average, the company has surpassed earnings expectations by 0.1559%, based on the last three reports.
Zhejiang Xinguang Pharmaceutical Co., Ltd. has completed 1 stock splits, with the recent split occurring on Jul 04, 2017.
The company's stock is traded on one exchange.

300519 Chart

People also search for

Dr Corp Ltd.
¥ 23.35
-2.4237%
Sunvim Group Co., Ltd.
¥ 11.72
-3.3003%
Tibet Gaozheng Explosive Co., Ltd.
¥ 58.61
-1.6281%
Innovative Medical Management Co., Ltd.
¥ 21.24
-3.1022%
Henan Liliang Diamond Co., Ltd.
¥ 59.21
-1.366%

Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519) FAQ

What is the stock price today?

The current price is ¥14.28.

On which exchange is it traded?

Zhejiang Xinguang Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300519.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.2%.

What is its market cap?

As of today, the market cap is 2.58B.

Has Zhejiang Xinguang Pharmaceutical Co., Ltd. ever had a stock split?

Zhejiang Xinguang Pharmaceutical Co., Ltd. had 1 splits and the recent split was on Jul 04, 2017.

Zhejiang Xinguang Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Yue Jun Wang CEO
XSHE Exchange
CNE1000027T3 ISIN
CN Country
316 Employees
29 May 2026 Last Dividend
4 Jul 2017 Last Split
- IPO Date

Overview

Zhejiang Xinguang Pharmaceutical Co., Ltd. is a prominent name in the pharmaceutical sector, focusing on the development, production, and distribution of a diverse range of healthcare products. Since its inception in 1998, the company has been committed to leveraging research and innovation to create effective treatments for various health conditions. With its headquarters firmly established in Shengzhou, China, Zhejiang Xinguang Pharmaceutical Co., Ltd. adheres to the highest standards of quality in all its offerings, ensuring they meet the needs and expectations of patients and healthcare providers alike.

Products and Services

  • Chinese Patent Medicines: Traditional remedies that have been adapted for modern healthcare needs. These medicines are the result of extensive research into historical medical practices, optimized with contemporary pharmaceutical techniques to treat a variety of ailments effectively.
  • Chemical Medicines: A wide range of synthetically produced drugs designed to target specific conditions with precision. These include medications for chronic and acute conditions, offering solutions across the spectrum of healthcare needs.
  • Health Food: Products developed to enhance overall well-being and prevent diseases. These health foods are formulated based on nutritional science and pharmaceutical expertise to support a healthy diet and lifestyle.
  • Pharmaceutical Products for Vascular and Trauma Diseases: Specialized medications aimed at managing and treating conditions related to the vascular system and injuries resulting from trauma. This category demonstrates the company’s commitment to addressing critical and complex health issues.
  • Respiratory System Medications: Treatments designed to alleviate and manage various disorders of the respiratory system, ensuring better breathing and lung function for patients suffering from such conditions.
  • Digestive System Treatments: A portfolio of products focused on improving digestive health and treating disorders related to the digestive tract, enhancing patients' quality of life through effective symptom management.
  • Urinary System Medications: Solutions for diseases and disorders affecting the urinary tract, providing relief and treatment options for patients dealing with these specific health concerns.
  • Pediatric Diseases Treatments: Medicines formulated especially for children, catering to the unique medical needs of young patients and ensuring safe and effective treatment for a wide range of childhood illnesses.
  • Immunity Improvement Products: Offerings aimed at strengthening the immune system, helping the body to fight off infections and diseases more effectively. These products are designed to support overall health and prevent illness.

Contact Information

Address: No. 25, Huancheng West Road, Shengzhou, China, 312400
Phone: 86 57 5832 92898